UNIGE document Scientific Article
previous document  unige:112288  next document
add to browser collection
Title

Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

Authors
Cerami, Chiara
Dubois, Bruno
Monsch, Andreas U
Demonet, Jean Francois
Cappa, Stefano F
Published in Neurobiology of Aging. 2017, vol. 52, p. 153-166
Abstract Although Alzheimer's disease criteria promote the use of biomarkers, their maturity in clinical routine still needs to be assessed. In the light of the oncology framework, we conducted a literature review on measures used to assess delayed recall impairment due to medial temporal lobe dysfunction (i.e., free and cued word list recall tests). Ample evidence is available for phases 1 (rationale for use), 2 (discriminative ability), and 3 (early detection ability) for many of the tests in routine use. Evidence about phase 4 (performance in real world) and phase 5 (quantify impact and costs) is yet to come. Administration procedures have been standardized and cutoff scores are well validated in large Alzheimer's disease and mild cognitive impaired series. Some aspects (e.g., different task formats), however, hamper the comparability of results among different populations and the reproducibility between laboratories. No definite guideline for their use can thus be proposed at the moment. Accordingly, the maturity of such markers is not yet sufficient and requires future investigation to promote the proper use of memory measures in clinical settings.
Keywords Alzheimer Disease/diagnosis/physiopathology/psychologyBiomarkers/analysisCognitive Dysfunction/diagnosis/psychologyCuesEarly DiagnosisHumansMemoryEpisodicMental RecallNeuropsychological TestsReproducibility of ResultsTemporal Lobe/physiopathology
Identifiers
PMID: 28317646
Full text
Article (Published version) (314 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Troubles de mémoire et maladie d'Alzeimer (935)
Citation
(ISO format)
CERAMI, Chiara et al. Clinical validity of delayed recall tests as a gateway biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. In: Neurobiology of Aging, 2017, vol. 52, p. 153-166. https://archive-ouverte.unige.ch/unige:112288

23 hits

0 download

Update

Deposited on : 2018-12-14

Export document
Format :
Citation style :